BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368:230-239. [PMID: 16844493 DOI: 10.1016/s0140-6736(06)69044-2] [Cited by in Crossref: 380] [Cited by in F6Publishing: 132] [Article Influence: 25.3] [Reference Citation Analysis]
Number Citing Articles
1 Th'ng F, Vliegenthart B, Lea JD, Antoine DJ, Dear JW, Mole DJ; Edinburgh Emergency Surgery Study Group, Royal Infirmary of Edinburgh, NHS Lothian. Evaluation of plasma microRNA-122, high-mobility group box 1 and keratin-18 concentrations to stratify acute gallstone disease: a pilot observational cohort study in an emergency general surgery unit. BMJ Open 2018;8:e020061. [PMID: 29703854 DOI: 10.1136/bmjopen-2017-020061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Di Ciaula A, Wang DQ, Bonfrate L, Portincasa P. Current views on genetics and epigenetics of cholesterol gallstone disease. Cholesterol. 2013;2013:298421. [PMID: 23691293 DOI: 10.1155/2013/298421] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
3 de Bari O, Wang TY, Liu M, Portincasa P, Wang DQ. Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice. J Lipid Res 2015;56:1691-700. [PMID: 26152119 DOI: 10.1194/jlr.M059121] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 4.2] [Reference Citation Analysis]
4 Brazzelli M, Cruickshank M, Kilonzo M, Ahmed I, Stewart F, McNamee P, Elders A, Fraser C, Avenell A, Ramsay C. Systematic review of the clinical and cost effectiveness of cholecystectomy versus observation/conservative management for uncomplicated symptomatic gallstones or cholecystitis. Surg Endosc. 2015;29:637-647. [PMID: 25119541 DOI: 10.1007/s00464-014-3712-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
5 El-Gendi A, El-Shafei M, Emara D. Emergency Versus Delayed Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in Grade II Acute Cholecystitis Patients. J Gastrointest Surg. 2017;21:284-293. [PMID: 27778253 DOI: 10.1007/s11605-016-3304-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
6 Ansari-Moghaddam A, Khorram A, Miri-Bonjar M, Mohammadi M, Ansari H. The Prevalence and Risk Factors of Gallstone Among Adults in South-East of Iran: A Population-Based Study. Glob J Health Sci 2015;8:60-7. [PMID: 26573029 DOI: 10.5539/gjhs.v8n4p60] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Takahashi Y, Yamamichi N, Shimamoto T, Mochizuki S, Fujishiro M, Takeuchi C, Sakaguchi Y, Niimi K, Ono S, Kodashima S, Mitsushima T, Koike K. Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan. J Gastroenterol 2014;49:882-9. [PMID: 23736795 DOI: 10.1007/s00535-013-0832-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
8 Ata N, Kucukazman M, Yavuz B, Bulus H, Dal K, Ertugrul DT, Yalcin AA, Polat M, Varol N, Akin KO, Karabag A, Nazligul Y. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol 2011;25:274-6. [PMID: 21647463 DOI: 10.1155/2011/356761] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
9 Wang HH, Portincasa P, Liu M, Tso P, Wang DQ. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13. Genes (Basel) 2020;11:E1438. [PMID: 33260332 DOI: 10.3390/genes11121438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xiong J, Wang Y, Huang H, Bian J, Wang A, Long J, Zheng Y, Sang X, Xu Y, Lu X, Zhao H. Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma. Oncotarget 2017;8:59648-57. [PMID: 28938668 DOI: 10.18632/oncotarget.19570] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
11 Wu J, Cui W, Cai Q, Fei J, Zhang SD, Han TQ, Hu H, Jiang ZY. The NPC1L1 Polymorphism 1679C>G Is Associated with Gallstone Disease in Chinese Patients. PLoS One 2016;11:e0147562. [PMID: 26800364 DOI: 10.1371/journal.pone.0147562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang G, Han T, Wang S, Chen M, Sun Y, Fu Z. Peroxisome Proliferator-Activated Receptor-γ Prevents Cholesterol Gallstone Formation in C57bl Mice by Regulating Bile Acid Synthesis and Enterohepatic Circulation. Biomed Res Int 2018;2018:7475626. [PMID: 30105244 DOI: 10.1155/2018/7475626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Di Ciaula A, Molina-Molina E, Bonfrate L, Wang DQ, Dumitrascu DL, Portincasa P. Gastrointestinal defects in gallstone and cholecystectomized patients. Eur J Clin Invest 2019;49:e13066. [PMID: 30592298 DOI: 10.1111/eci.13066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gribsholt SB, Pedersen L, Richelsen B, Dekkers O, Thomsen RW. Body Mass Index of 92,027 patients acutely admitted to general hospitals in Denmark: Associated clinical characteristics and 30-day mortality. PLoS One 2018;13:e0195853. [PMID: 29659630 DOI: 10.1371/journal.pone.0195853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Milton JN, Sebastiani P, Solovieff N, Hartley SW, Bhatnagar P, Arking DE, Dworkis DA, Casella JF, Barron-Casella E, Bean CJ, Hooper WC, DeBaun MR, Garrett ME, Soldano K, Telen MJ, Ashley-Koch A, Gladwin MT, Baldwin CT, Steinberg MH, Klings ES. A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. PLoS One 2012;7:e34741. [PMID: 22558097 DOI: 10.1371/journal.pone.0034741] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
16 Zheng Y, Xu M, Li Y, Hruby A, Rimm EB, Hu FB, Wirth J, Albert CM, Rexrode KM, Manson JE, Qi L. Gallstones and Risk of Coronary Heart Disease: Prospective Analysis of 270 000 Men and Women From 3 US Cohorts and Meta-Analysis. Arterioscler Thromb Vasc Biol 2016;36:1997-2003. [PMID: 27540264 DOI: 10.1161/ATVBAHA.116.307507] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
17 Vázquez MC, Rigotti A, Zanlungo S. Molecular Mechanisms Underlying the Link between Nuclear Receptor Function and Cholesterol Gallstone Formation. J Lipids 2012;2012:547643. [PMID: 22132343 DOI: 10.1155/2012/547643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
18 Huang SZ, Chen HQ, Liao WX, Zhou WY, Chen JH, Li WC, Zhou H, Liu B, Hu KP. Comparison of emergency cholecystectomy and delayed cholecystectomy after percutaneous transhepatic gallbladder drainage in patients with acute cholecystitis: a systematic review and meta-analysis. Updates Surg 2021;73:481-94. [PMID: 33048340 DOI: 10.1007/s13304-020-00894-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Racine A, Bijon A, Fournier A, Mesrine S, Clavel-Chapelon F, Carbonnel F, Boutron-Ruault MC. Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort. CMAJ 2013;185:555-61. [PMID: 23509128 DOI: 10.1503/cmaj.121490] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
20 Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3(2): 7-20 [PMID: 22577615 DOI: 10.4292/wjgpt.v3.i2.7] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
21 Chen G, Wu S. Role of Baicalin and Liver X Receptor Alpha in the Formation of Cholesterol Gallstones in Mice. Gastroenterol Res Pract 2020;2020:1343969. [PMID: 32382260 DOI: 10.1155/2020/1343969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Fan Y, Wu S, Fu B, Weng C, Wang X. The role of interstitial Cajal-like cells in the formation of cholesterol stones in guinea pig gallbladder. Hepatol Int. 2015;9:612-620. [PMID: 25788205 DOI: 10.1007/s12072-015-9623-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
23 Bertolotti M, Mussi C, Pellegrini E, Magni A, Del Puppo M, Ognibene S, Carulli L, Anzivino C, Baldelli E, Loria P. Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. Clin Interv Aging. 2014;9:425-432. [PMID: 24669190 DOI: 10.2147/cia.s57714] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
24 Nexøe-Larsen CC, Sørensen PH, Hausner H, Agersnap M, Baekdal M, Brønden A, Gustafsson LN, Sonne DP, Vedtofte L, Vilsbøll T, Knop FK. Effects of liraglutide on gallbladder emptying: A randomized, placebo-controlled trial in adults with overweight or obesity. Diabetes Obes Metab 2018;20:2557-64. [PMID: 29892986 DOI: 10.1111/dom.13420] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
25 Han T, Lv Y, Wang S, Hu T, Hong H, Fu Z. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet. Lipids Health Dis 2019;18:218. [PMID: 31829191 DOI: 10.1186/s12944-019-1159-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Shen TC, Lai HC, Huang YJ, Lin CL, Sung FC, Kao CH. The risk of depression in patients with cholelithiasis before and after cholecystectomy: a population-based cohort study. Medicine (Baltimore) 2015;94:e631. [PMID: 25761193 DOI: 10.1097/MD.0000000000000631] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Ferkingstad E, Oddsson A, Gretarsdottir S, Benonisdottir S, Thorleifsson G, Deaton AM, Jonsson S, Stefansson OA, Norddahl GL, Zink F, Arnadottir GA, Gunnarsson B, Halldorsson GH, Helgadottir A, Jensson BO, Kristjansson RP, Sveinbjornsson G, Sverrisson DA, Masson G, Olafsson I, Eyjolfsson GI, Sigurdardottir O, Holm H, Jonsdottir I, Olafsson S, Steingrimsdottir T, Rafnar T, Bjornsson ES, Thorsteinsdottir U, Gudbjartsson DF, Sulem P, Stefansson K. Genome-wide association meta-analysis yields 20 loci associated with gallstone disease. Nat Commun 2018;9:5101. [PMID: 30504769 DOI: 10.1038/s41467-018-07460-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
28 Gandhi J, Tan J. Concurrent presentation of appendicitis and acute cholecystitis: diagnosis of rare occurrence. BMJ Case Rep 2015;2015:bcr2014208916. [PMID: 26396122 DOI: 10.1136/bcr-2014-208916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Wu T, Zhang Z, Liu B, Hou D, Liang Y, Zhang J, Shi P. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics. 2013;14:669. [PMID: 24083370 DOI: 10.1186/1471-2164-14-669] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 10.8] [Reference Citation Analysis]
30 Lv J, Yu C, Guo Y, Bian Z, Yang L, Chen Y, Li S, Huang Y, Fu Y, He P, Tang A, Chen J, Chen Z, Qi L, Li L. Gallstone Disease and the Risk of Type 2 Diabetes. Sci Rep 2017;7:15853. [PMID: 29158491 DOI: 10.1038/s41598-017-14801-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
31 Kim KH, Han SM, Jeon KO, Kim HT, Li Q, Ryu MO, Song WJ, Park SC, Youn HY. Clinical Relationship between Cholestatic Disease and Pituitary-Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series. J Vet Intern Med 2017;31:335-42. [PMID: 28064467 DOI: 10.1111/jvim.14608] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
32 Jaruvongvanich V, Sanguankeo A, Upala S. Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2016;61:2389-2396. [PMID: 26993825 DOI: 10.1007/s10620-016-4125-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
33 Jiang ZY, Cai Q, Chen EZ. Association of three common single nucleotide polymorphisms of ATP binding cassette G8 gene with gallstone disease: a meta-analysis. PLoS One 2014;9:e87200. [PMID: 24498041 DOI: 10.1371/journal.pone.0087200] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
34 Pang Y, Kartsonaki C, Lv J, Millwood IY, Yu C, Guo Y, Chen Y, Bian Z, Yang L, Chen J, Clarke R, Walters R, Wu S, Li H, Holmes MV, Li L, Chen Z. Observational and Genetic Associations of Body Mass Index and Hepatobiliary Diseases in a Relatively Lean Chinese Population. JAMA Netw Open 2020;3:e2018721. [PMID: 33006619 DOI: 10.1001/jamanetworkopen.2020.18721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 He J, Nishida S, Xu M, Makishima M, Xie W. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology 2011;140:2095-106. [PMID: 21354151 DOI: 10.1053/j.gastro.2011.02.055] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
36 Pulkkinen J, Eskelinen M, Kiviniemi V, Kotilainen T, Pöyhönen M, Kilpeläinen L, Käkelä P, Kastarinen H, Paajanen H. Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study. BMC Gastroenterol 2014;14:119. [PMID: 24993977 DOI: 10.1186/1471-230X-14-119] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
37 Joshi AD, Andersson C, Buch S, Stender S, Noordam R, Weng LC, Weeke PE, Auer PL, Boehm B, Chen C, Choi H, Curhan G, Denny JC, De Vivo I, Eicher JD, Ellinghaus D, Folsom AR, Fuchs C, Gala M, Haessler J, Hofman A, Hu F, Hunter DJ, Janssen HL, Kang JH, Kooperberg C, Kraft P, Kratzer W, Lieb W, Lutsey PL, Darwish Murad S, Nordestgaard BG, Pasquale LR, Reiner AP, Ridker PM, Rimm E, Rose LM, Shaffer CM, Schafmayer C, Tamimi RM, Uitterlinden AG, Völker U, Völzke H, Wakabayashi Y, Wiggs JL, Zhu J, Roden DM, Stricker BH, Tang W, Teumer A, Hampe J, Tybjærg-Hansen A, Chasman DI, Chan AT, Johnson AD. Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. Gastroenterology 2016;151:351-363.e28. [PMID: 27094239 DOI: 10.1053/j.gastro.2016.04.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
38 Lin J, Shao WQ, Chen QZ, Zhu WW, Lu L, Jia HL, Chen JH. Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1. Mol Med Rep 2017;16:1785-92. [PMID: 28627641 DOI: 10.3892/mmr.2017.6774] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Dong C, Condat B, Picon-Coste M, Chrétien Y, Potier P, Noblinski B, Arrivé L, Hauuy MP, Barbu V, Maftouh A, Gaouar F, Ben Belkacem K, Housset C, Poupon R, Zanditenas D, Chazouillères O, Corpechot C. Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities. JHEP Rep 2021;3:100201. [PMID: 33554096 DOI: 10.1016/j.jhepr.2020.100201] [Reference Citation Analysis]
40 Renner O, Harsch S, Schaeffeler E, Winter S, Schwab M, Krawczyk M, Rosendahl J, Wittenburg H, Lammert F, Stange EF. A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease. PLoS One 2009;4:e7321. [PMID: 19823678 DOI: 10.1371/journal.pone.0007321] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
41 Castro-Torres IG, Naranjo-Rodríguez EB, Domínguez-Ortíz MÁ, Gallegos-Estudillo J, Saavedra-Vélez MV. Antilithiasic and hypolipidaemic effects of Raphanus sativus L. var. niger on mice fed with a lithogenic diet. J Biomed Biotechnol 2012;2012:161205. [PMID: 23093836 DOI: 10.1155/2012/161205] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ma W, Li Y, Heianza Y, Staller KD, Chan AT, Rimm EB, Rexrode KM, Qi L. Associations of Bowel Movement Frequency with Risk of Cardiovascular Disease and Mortality among US Women. Sci Rep 2016;6:33005. [PMID: 27596972 DOI: 10.1038/srep33005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
43 Di Ciaula A, Garruti G, Wang DQ, Portincasa P. Cholecystectomy and risk of metabolic syndrome. Eur J Intern Med 2018;53:3-11. [PMID: 29706426 DOI: 10.1016/j.ejim.2018.04.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
44 Modica S, Gadaleta RM, Moschetta A. Deciphering the nuclear bile acid receptor FXR paradigm. Nucl Recept Signal. 2010;8:e005. [PMID: 21383957 DOI: 10.1621/nrs.08005] [Cited by in Crossref: 160] [Cited by in F6Publishing: 158] [Article Influence: 14.5] [Reference Citation Analysis]
45 Cui W, Jiang ZY, Cai Q, Zhang RY, Wu WZ, Wang JC, Fei J, Zhang SD, Han TQ. Decreased NPC1L1 expression in the liver from Chinese female gallstone patients. Lipids Health Dis 2010;9:17. [PMID: 20144195 DOI: 10.1186/1476-511X-9-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
46 Gill L, Mackey S. Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor Agonists. J Womens Health (Larchmt) 2021;30:1016-27. [PMID: 33626287 DOI: 10.1089/jwh.2020.8683] [Reference Citation Analysis]
47 Wang HH, Portincasa P, Liu M, Tso P, Samuelson LC, Wang DQ. Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice. Biochim Biophys Acta 2010;1801:138-46. [PMID: 19836465 DOI: 10.1016/j.bbalip.2009.10.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
48 Zhang FM, Yu CH, Chen HT, Shen Z, Hu FL, Yuan XP, Xu GQ. Helicobacter pylori infection is associated with gallstones: Epidemiological survey in China. World J Gastroenterol 2015; 21(29): 8912-8919 [PMID: 26269681 DOI: 10.3748/wjg.v21.i29.8912] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
49 Shen HJ, Hsu CT, Tung TH. Economic and medical benefits of ultrasound screenings for gallstone disease. World J Gastroenterol 2015; 21(11): 3337-3343 [PMID: 25805942 DOI: 10.3748/wjg.v21.i11.3337] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Li X, Guo X, Ji H, Yu G, Gao P. Gallstones in Patients with Chronic Liver Diseases. Biomed Res Int 2017;2017:9749802. [PMID: 28251162 DOI: 10.1155/2017/9749802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
51 Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology. 2011;140:508-516. [PMID: 21075109 DOI: 10.1053/j.gastro.2010.10.060] [Cited by in Crossref: 109] [Cited by in F6Publishing: 79] [Article Influence: 9.9] [Reference Citation Analysis]
52 Wang HH, Portincasa P, Mendez-Sanchez N, Uribe M, Wang DQ. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology. 2008;134:2101-2110. [PMID: 18442485 DOI: 10.1053/j.gastro.2008.03.011] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 8.2] [Reference Citation Analysis]
53 de Bari O, Neuschwander-Tetri BA, Liu M, Portincasa P, Wang DQ. Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. J Lipids. 2012;2012:302847. [PMID: 22132342 DOI: 10.1155/2012/302847] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
54 Molinero N, Ruiz L, Milani C, Gutiérrez-Díaz I, Sánchez B, Mangifesta M, Segura J, Cambero I, Campelo AB, García-Bernardo CM, Cabrera A, Rodríguez JI, González S, Rodríguez JM, Ventura M, Delgado S, Margolles A. The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile. Microbiome 2019;7:100. [PMID: 31272480 DOI: 10.1186/s40168-019-0712-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
55 Stokes CS, Lammert F. Excess Body Weight and Gallstone Disease. Visc Med 2021;37:254-60. [PMID: 34540940 DOI: 10.1159/000516418] [Reference Citation Analysis]
56 Kim HS, Cho SK, Kim CS, Park JS. Big data and analysis of risk factors for gallbladder disease in the young generation of Korea. PLoS One 2019;14:e0211480. [PMID: 30794560 DOI: 10.1371/journal.pone.0211480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
57 Jaime SC, Maribel AM, Eliakym AM, José RN, Julio G, Laura SM, Rosalío RP. ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease. World J Gastroenterol 2010; 16(37): 4685-4690 [PMID: 20872969 DOI: 10.3748/wjg.v16.i37.4685] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
58 Shephard RJ. Physical Activity and the Biliary Tract in Health and Disease. Sports Med 2015;45:1295-309. [PMID: 26068960 DOI: 10.1007/s40279-015-0346-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
59 Tiderington E, Lee SP, Ko CW. Gallstones: new insights into an old story. F1000Res 2016;5:F1000 Faculty Rev-1817. [PMID: 27508070 DOI: 10.12688/f1000research.8874.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
60 Dawson PA. Role of the intestinal bile acid transporters in bile acid and drug disposition. Handb Exp Pharmacol 2011;:169-203. [PMID: 21103970 DOI: 10.1007/978-3-642-14541-4_4] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 11.1] [Reference Citation Analysis]
61 Strnad P, von Figura G, Gruss R, Jareis KM, Stiehl A, Kulaksiz H. Oblique bile duct predisposes to the recurrence of bile duct stones. PLoS One. 2013;8:e54601. [PMID: 23365676 DOI: 10.1371/journal.pone.0054601] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
62 Maurer KJ, Carey MC, Fox JG. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 2009;136:425-40. [PMID: 19109959 DOI: 10.1053/j.gastro.2008.12.031] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
63 Ata N, Kucukazman M, Yavuz B, Bulus H, Dal K, Ertugrul DT, Yalcin AA, Polat M, Varol N, Akin KO. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol. 2011;25:274-276. [PMID: 21647463 DOI: 10.1371/journal.pone.0088189] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
64 Xiang Y, Kong X, Zhang C, He C, Cai J, Lu R, Zhang B, Lu L, Yang Y. Free fatty acids and triglyceride change in the gallbladder bile of gallstone patients with pancreaticobiliary reflux. Lipids Health Dis 2021;20:97. [PMID: 34465364 DOI: 10.1186/s12944-021-01527-4] [Reference Citation Analysis]
65 Silvennoinen R, Quesada H, Kareinen I, Julve J, Kaipiainen L, Gylling H, Blanco-Vaca F, Escola-Gil JC, Kovanen PT, Lee-Rueckert M. Chronic intermittent psychological stress promotes macrophage reverse cholesterol transport by impairing bile acid absorption in mice. Physiol Rep 2015;3:e12402. [PMID: 25969465 DOI: 10.14814/phy2.12402] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
66 Molina-Molina E, Lunardi Baccetto R, Wang DQ, de Bari O, Krawczyk M, Portincasa P. Exercising the hepatobiliary-gut axis. The impact of physical activity performance. Eur J Clin Invest. 2018;48:e12958. [PMID: 29797516 DOI: 10.1111/eci.12958] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
67 Gong Y, Zhang L, Bie P, Wang H. Roles of ApoB-100 gene polymorphisms and the risks of gallstones and gallbladder cancer: a meta-analysis. PLoS One 2013;8:e61456. [PMID: 23637837 DOI: 10.1371/journal.pone.0061456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
68 Warren T, McAllister R, Morgan A, Rai TS, McGilligan V, Ennis M, Page C, Kelly C, Peace A, Corfe BM, Mc Auley M, Watterson S. The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism. Cells 2021;10:2007. [PMID: 34440777 DOI: 10.3390/cells10082007] [Reference Citation Analysis]
69 Meng Y, Meng K, Zhao X, Li D, Gao Q, Wu S, Cui Y. Protective Effects of Yinchenhao Decoction on Cholesterol Gallstone in Mice Fed a Lithogenic Diet by Regulating LXR, CYP7A1, CYP7B1, and HMGCR Pathways. Evid Based Complement Alternat Med 2018;2018:8134918. [PMID: 30310412 DOI: 10.1155/2018/8134918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Nada T, Sato M, Yoshikawa T, Ogura M, Kamei K. Cholelithiasis in infants with congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 2021. [PMID: 34383124 DOI: 10.1007/s00467-021-05225-2] [Reference Citation Analysis]
71 Herzog D, Bouchard G. High rate of complicated idiopathic gallstone disease in pediatric patients of a North American tertiary care center. World J Gastroenterol 2008; 14(10): 1544-1548 [PMID: 18330945 DOI: 10.3748/wjg.14.1544] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
72 Christensen RM, Juhl CR, Torekov SS. Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists. Drug Saf 2019;42:957-71. [DOI: 10.1007/s40264-019-00812-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
73 Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res. 2018;7. [PMID: 30345010 DOI: 10.12688/f1000research.15505.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
74 Olaiya MT, Chiou HY, Jeng JS, Lien LM, Hsieh FI. Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort study. PLoS One 2013;8:e76448. [PMID: 24098504 DOI: 10.1371/journal.pone.0076448] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
75 Hussan H, Ugbarugba E, Porter K, Noria S, Needleman B, Clinton SK, Conwell DL, Krishna SG. The Type of Bariatric Surgery Impacts the Risk of Acute Pancreatitis: A Nationwide Study. Clin Transl Gastroenterol 2018;9:179. [PMID: 30206217 DOI: 10.1038/s41424-018-0045-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
76 Murray AC, Markar S, Mackenzie H, Baser O, Wiggins T, Askari A, Hanna G, Faiz O, Mayer E, Bicknell C, Darzi A, Kiran RP. An observational study of the timing of surgery, use of laparoscopy and outcomes for acute cholecystitis in the USA and UK. Surg Endosc 2018;32:3055-63. [PMID: 29313126 DOI: 10.1007/s00464-017-6016-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
77 Wang Y, Yu X, Zhao QZ, Zheng S, Qing WJ, Miao CD, Sanjay J. Thyroid dysfunction, either hyper or hypothyroidism, promotes gallstone formation by different mechanisms. J Zhejiang Univ Sci B 2016;17:515-25. [PMID: 27381728 DOI: 10.1631/jzus.B1500210] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
78 Matyja A, Gil K, Pasternak A, Sztefko K, Gajda M, Tomaszewski KA, Matyja M, Walocha JA, Kulig J, Thor P. Telocytes: new insight into the pathogenesis of gallstone disease. J Cell Mol Med 2013;17:734-42. [PMID: 23551596 DOI: 10.1111/jcmm.12057] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
79 Zhu Q, Sun X, Ji X, Zhu L, Xu J, Wang C, Zhang C, Xue F, Liu Y. The association between gallstones and metabolic syndrome in urban Han Chinese: A longitudinal cohort study. Sci Rep. 2016;6:29937. [PMID: 27443986 DOI: 10.1038/srep29937] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
80 Bang CS, Yoon JH, Kim YJ, Kim JB, Baik GH, Suk KT, Kim YS, Kim DJ. Clinical impact of body mass index on bactibilia and bacteremia. BMC Gastroenterol 2014;14:104. [PMID: 24902609 DOI: 10.1186/1471-230X-14-104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
81 Tsaroucha AK, Chatzaki E, Lambropoulou M, Despoudi K, Laftsidis P, Charsou C, Polychronidis A, Papadopoulos N, Simopoulos CE. Megalin and cubilin in the human gallbladder epithelium. Clin Exp Med 2008;8:165-70. [PMID: 18791690 DOI: 10.1007/s10238-008-0174-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
82 Hyun JJ, Lee HS, Kim CD, Dong SH, Lee SO, Ryu JK, Lee DH, Jeong S, Kim TN, Lee J, Koh DH, Park ET, Lee IS, Yoo BM, Kim JH. Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial. Gut Liver 2015;9:547-55. [PMID: 26087862 DOI: 10.5009/gnl15015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
83 Zhang D, Xiang J, Wang L, Xu Z, Sun L, Zhou F, Zha X, Cai D. Comparative proteomic analysis of gallbladder bile proteins related to cholesterol gallstones. PLoS One 2013;8:e54489. [PMID: 23349907 DOI: 10.1371/journal.pone.0054489] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
84 Gutiérrez-Díaz I, Molinero N, Cabrera A, Rodríguez JI, Margolles A, Delgado S, González S. Diet: Cause or Consequence of the Microbial Profile of Cholelithiasis Disease? Nutrients 2018;10:E1307. [PMID: 30223526 DOI: 10.3390/nu10091307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
85 Di Ciaula A, Wang DQ, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol 2018;34:71-80. [PMID: 29283909 DOI: 10.1097/MOG.0000000000000423] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 18.5] [Reference Citation Analysis]
86 Molvar C, Glaenzer B. Choledocholithiasis: Evaluation, Treatment, and Outcomes. Semin Intervent Radiol 2016;33:268-76. [PMID: 27904245 DOI: 10.1055/s-0036-1592329] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
87 Di Ciaula A, Calamita G, Shanmugam H, Khalil M, Bonfrate L, Wang DQ, Baffy G, Portincasa P. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests. Int J Mol Sci 2021;22:7702. [PMID: 34299321 DOI: 10.3390/ijms22147702] [Reference Citation Analysis]
88 Di Ciaula A, Wang DQ, Wang HH, Bonfrate L, Portincasa P. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am 2010;39:245-64, viii-ix. [PMID: 20478485 DOI: 10.1016/j.gtc.2010.02.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
89 Portincasa P, Di Ciaula A, Grattagliano I. Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians. Korean J Fam Med 2016;37:205-13. [PMID: 27468338 DOI: 10.4082/kjfm.2016.37.4.205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
90 Rudzińska K, Bogacz A, Kotrych D, Wolski H, Majchrzycki M, Seremak-Mrozikiewicz A, Kosiński B, Czerny B. The APOB gene polymorphism in the pathogenesis of gallstone disease in pre- and postmenopausal women. Prz Menopauzalny 2015;14:35-40. [PMID: 26327886 DOI: 10.5114/pm.2015.49169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
91 Chang HY, Wang CJ, Liu B, Wang YZ, Wang WJ, Wang W, Li D, Li YL. Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones. World J Gastroenterol 2018; 24(39): 4489-4498 [PMID: 30356997 DOI: 10.3748/wjg.v24.i39.4489] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
92 Cariati A. Gallstone Classification in Western Countries. Indian J Surg 2015;77:376-80. [PMID: 26730029 DOI: 10.1007/s12262-013-0847-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
93 Tharp KM, Khalifeh-Soltani A, Park HM, Yurek DA, Falcon A, Wong L, Feng R, Atabai K, Stahl A. Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis. Am J Physiol Gastrointest Liver Physiol 2016;310:G855-64. [PMID: 27033116 DOI: 10.1152/ajpgi.00316.2015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
94 Portincasa P, van Erpecum KJ, Di Ciaula A, Wang DQ. The physical presence of gallstone modulates ex vivo cholesterol crystallization pathways of human bile. Gastroenterol Rep (Oxf) 2019;7:32-41. [PMID: 30792864 DOI: 10.1093/gastro/goy044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
95 Chang CM, Chiu THT, Chang CC, Lin MN, Lin CL. Plant-Based Diet, Cholesterol, and Risk of Gallstone Disease: A Prospective Study. Nutrients. 2019;11:335. [PMID: 30720747 DOI: 10.3390/nu11020335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Fairfield CJ, Wigmore SJ, Harrison EM. Gallstone Disease and the Risk of Cardiovascular Disease. Sci Rep 2019;9:5830. [PMID: 30967586 DOI: 10.1038/s41598-019-42327-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
97 Ryu S, Chang Y, Yun KE, Jung HS, Shin JH, Shin H. Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study. Am J Gastroenterol 2016;111:1476-87. [PMID: 27575712 DOI: 10.1038/ajg.2016.345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
98 Wang Q, Jiao L, He C, Sun H, Cai Q, Han T, Hu H. Alteration of gut microbiota in association with cholesterol gallstone formation in mice. BMC Gastroenterol 2017;17:74. [PMID: 28599622 DOI: 10.1186/s12876-017-0629-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
99 Nordenvall C, Oskarsson V, Wolk A. Fruit and vegetable consumption and risk of cholecystectomy: a prospective cohort study of women and men. Eur J Nutr 2018;57:75-81. [PMID: 27544676 DOI: 10.1007/s00394-016-1298-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
100 Rai AA, Nazeer A, Luck NH. Frequency of gallstones and mean BMI in decompensated cirrhosis. Pan Afr Med J 2018;30:123. [PMID: 30374369 DOI: 10.11604/pamj.2018.30.123.12742] [Reference Citation Analysis]
101 Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, Agresta F, Allegri A, Bailey I, Balogh ZJ, Bendinelli C, Biffl W, Bonavina L, Borzellino G, Brunetti F, Burlew CC, Camapanelli G, Campanile FC, Ceresoli M, Chiara O, Civil I, Coimbra R, De Moya M, Di Saverio S, Fraga GP, Gupta S, Kashuk J, Kelly MD, Koka V, Jeekel H, Latifi R, Leppaniemi A, Maier RV, Marzi I, Moore F, Piazzalunga D, Sakakushev B, Sartelli M, Scalea T, Stahel PF, Taviloglu K, Tugnoli G, Uraneus S, Velmahos GC, Wani I, Weber DG, Viale P, Sugrue M, Ivatury R, Kluger Y, Gurusamy KS, Moore EE. 2016 WSES guidelines on acute calculous cholecystitis. World J Emerg Surg. 2016;11:25. [PMID: 27307785 DOI: 10.1186/s13017-016-0082-5] [Cited by in Crossref: 136] [Cited by in F6Publishing: 95] [Article Influence: 27.2] [Reference Citation Analysis]
102 Di Ciaula A, Garruti G, Frühbeck G, De Angelis M, de Bari O, Wang DQ, Lammert F, Portincasa P. The Role of Diet in the Pathogenesis of Cholesterol Gallstones. Curr Med Chem 2019;26:3620-38. [PMID: 28554328 DOI: 10.2174/0929867324666170530080636] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
103 Brighi N, Panzuto F, Modica R, Gelsomino F, Albertelli M, Pusceddu S, Massironi S, Lamberti G, Rinzivillo M, Faggiano A, Spallanzani A, Ferone D, Prinzi N, Rossi RE, Annibale B, Colao AM, Campana D. Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study. Oncologist 2020;25:259-65. [PMID: 32162819 DOI: 10.1634/theoncologist.2019-0403] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
104 Wang HH, Lammert F, Schmitz A, Wang DQ. Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice. Eur J Clin Invest 2010;40:541-51. [PMID: 20456485 DOI: 10.1111/j.1365-2362.2010.02300.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
105 Xiao M, Yang M, Ji X, Li D, Xie Y, Lyu Y, Zuo Z. Protective effect of Glechoma hederacea extract against gallstone formation in rodent models. BMC Complement Med Ther 2021;21:199. [PMID: 34261471 DOI: 10.1186/s12906-021-03368-1] [Reference Citation Analysis]
106 Hung SC, Liao KF, Lai SW, Li CI, Chen WC. Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol. 2011;11:111. [PMID: 21999925 DOI: 10.1186/1471-230x-11-111] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
107 Wang HH, Liu M, Portincasa P, Wang DQ. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease. Adv Exp Med Biol 2020;1276:105-36. [PMID: 32705597 DOI: 10.1007/978-981-15-6082-8_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Li H, Yao QZ, Wang YY, Li YL, Zhou GT. Biomimetic synthesis of struvite with biogenic morphology and implication for pathological biomineralization. Sci Rep 2015;5:7718. [PMID: 25591814 DOI: 10.1038/srep07718] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
109 Ahmed I, Innes K, Brazzelli M, Gillies K, Newlands R, Avenell A, Hernández R, Blazeby J, Croal B, Hudson J, MacLennan G, McCormack K, McDonald A, Murchie P, Ramsay C. Protocol for a randomised controlled trial comparing laparoscopic cholecystectomy with observation/conservative management for preventing recurrent symptoms and complications in adults with uncomplicated symptomatic gallstones (C-Gall trial). BMJ Open 2021;11:e039781. [PMID: 33766835 DOI: 10.1136/bmjopen-2020-039781] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
110 Chang YR, Jang JY, Kwon W, Park JW, Kang MJ, Ryu JK, Kim YT, Yun YB, Kim SW. Changes in demographic features of gallstone disease: 30 years of surgically treated patients. Gut Liver. 2013;7:719-724. [PMID: 24312714 DOI: 10.5009/gnl.2013.7.6.719] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
111 Lv J, Qi L, Yu C, Guo Y, Bian Z, Chen Y, Yang L, Shen J, Wang S, Li M, Liu Y, Zhang L, Chen J, Chen Z, Li L; China Kadoorie Biobank Collaborative Group*. Gallstone Disease and the Risk of Ischemic Heart Disease. Arterioscler Thromb Vasc Biol 2015;35:2232-7. [PMID: 26272939 DOI: 10.1161/ATVBAHA.115.306043] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
112 Patel DK, Stanford FC. Safety and tolerability of new-generation anti-obesity medications: a narrative review. Postgrad Med 2018;130:173-82. [PMID: 29388462 DOI: 10.1080/00325481.2018.1435129] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 14.7] [Reference Citation Analysis]
113 Menahem B, Mulliri A, Fohlen A, Guittet L, Alves A, Lubrano J. Delayed laparoscopic cholecystectomy increases the total hospital stay compared to an early laparoscopic cholecystectomy after acute cholecystitis: an updated meta-analysis of randomized controlled trials. HPB (Oxford). 2015;17:857-862. [PMID: 26218858 DOI: 10.1111/hpb.12449] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
114 Mou D, Tesfasilassie T, Hirji S, Ashley SW. Advances in the management of acute cholecystitis. Ann Gastroenterol Surg. 2019;3:247-253. [PMID: 31131353 DOI: 10.1002/ags3.12240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
115 Herrera J, Amigo L, Husche C, Benítez C, Zanlungo S, Lütjohann D, Miquel JF, Nervi F. Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients. Lipids Health Dis 2009;8:53. [PMID: 19995447 DOI: 10.1186/1476-511X-8-53] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Shabanzadeh DM, Sørensen LT, Jørgensen T. Abdominal Symptoms and Incident Gallstones in a Population Unaware of Gallstone Status. Can J Gastroenterol Hepatol 2016;2016:9730687. [PMID: 27504440 DOI: 10.1155/2016/9730687] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
117 Lin J, Lu M, Shao WQ, Chen ZY, Zhu WW, Lu L, Jia HL, Cai D, Qin LX, Chen JH. Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation. Sci Rep 2016;6:30215. [PMID: 27484115 DOI: 10.1038/srep30215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
118 Zhou B, Hu J, Zhong Y. Surgical treatments for patients with recurrent bile duct stones and Oddis sphincter laxity. Intractable Rare Dis Res 2017;6:172-6. [PMID: 28944138 DOI: 10.5582/irdr.2017.01053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
119 Shi X, Jin S, Wang S, Tao W, Wang G. Gallbladder perforation in a patient with alcoholic liver cirrhosis and asymptomatic gallstones: A case report. Medicine (Baltimore) 2018;97:e0414. [PMID: 29718836 DOI: 10.1097/MD.0000000000010414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Stein A, Hermoni D, Elis A, Konikoff FM. Effect of ezetimibe on the prevalence of cholelithiasis. World J Gastroenterol 2012; 18(40): 5789-5792 [PMID: 23155321 DOI: 10.3748/wjg.v18.i40.5789] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
121 Yan HL, Lin B, Lu Q, Lei TT, Ma HS, Yang JL. Gallbladder bleeding along with cholecystocolonic fistula: a case report. Gastroenterol Rep (Oxf) 2021;9:81-4. [PMID: 33747530 DOI: 10.1093/gastro/goaa034] [Reference Citation Analysis]
122 Rahmani V, Molazem M, Jamshidi S, Vali Y, Hanifeh M. Evaluation of gallbladder volume and contraction index with three-dimensional ultrasonography in healthy dogs. J Vet Med Sci 2015;77:1157-61. [PMID: 25903917 DOI: 10.1292/jvms.14-0537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
123 Chang Y, Noh YH, Suh BS, Kim Y, Sung E, Jung HS, Kim CW, Kwon MJ, Yun KE, Noh JW, Shin H, Cho YK, Ryu S. Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study. J Clin Med. 2018;7:458. [PMID: 30469392 DOI: 10.3390/jcm7110458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
124 Miyasaka K, Kanai S, Ohta M, Sekime A, Akimoto S, Takiguchi S, Funakoshi A. Susceptibility to obesity and gallbladder stasis produced by a protein- and fat-enriched diet in male mice compared with female mice. Nutr Metab (Lond) 2007;4:14. [PMID: 17547774 DOI: 10.1186/1743-7075-4-14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
125 Wang HH, Portincasa P, Wang DQ. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones. Curr Med Chem 2019;26:3407-23. [PMID: 28625150 DOI: 10.2174/0929867324666170619104801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
126 Yang L, Chen JH, Cai D, Wang LY, Zha XL. Osteopontin and integrin are involved in cholesterol gallstone formation. Med Sci Monit 2012;18:BR16-23. [PMID: 22207105 DOI: 10.12659/msm.882194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
127 Dikkers A, Tietge UJ. Biliary cholesterol secretion: More than a simple ABC. World J Gastroenterol 2010; 16(47): 5936-5945 [PMID: 21157969 DOI: 10.3748/wjg.v16.i47.5936] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
128 Haal S, Rondagh D, Hutten BA, Acherman YIZ, van de Laar AWJM, Huijgen R, Gerdes VEA, Voermans RP. Risk Factors for Cholecystectomy After Laparoscopic Roux-En-Y Gastric Bypass. Obes Surg 2020;30:507-14. [PMID: 31745862 DOI: 10.1007/s11695-019-04166-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
129 Zanghì G, Leanza V, Vecchio R, Malaguarnera M, Romano G, Rinzivillo NM, Catania V, Basile F. Single-Incision Laparoscopic Cholecystectomy: our experience and review of literature. G Chir 2015;36:243-6. [PMID: 26888698 DOI: 10.11138/gchir/2015.36.6.243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
130 Shanmugam H, Molina Molina E, Di Palo DM, Faienza MF, Di Ciaula A, Garruti G, Wang DQH, Portincasa P. Physical Activity Modulating Lipid Metabolism in Gallbladder Diseases. J Gastrointestin Liver Dis 2020;29:99-110. [PMID: 32176752 DOI: 10.15403/jgld-544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Xu GQ, Xu CF, Chen HT, Liu S, Teng XD, Xu GY, Yu CH. Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice. World J Gastroenterol 2014; 20(28): 9513-9518 [PMID: 25071346 DOI: 10.3748/wjg.v20.i28.9513] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
132 Portincasa P, Molina-Molina E, Garruti G, Wang DQ. Critical Care Aspects of Gallstone Disease. J Crit Care Med (Targu Mures) 2019;5:6-18. [PMID: 30766918 DOI: 10.2478/jccm-2019-0003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]